HERTFORDSHIRE, England, and
PITTSBURGH, April 26, 2019 /PRNewswire/ -- Global
pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced
that it will release its first quarter 2019 financial results on
Tues., May 7, before the open of the
U.S. financial markets. The company also will host a webcast at
10 a.m. ET on May 7, to discuss the results.
The briefing can be accessed live by
calling 855.493.3607 or 346.354.0950 for
international callers (ID#: 4992316) or at the following address on
the company's website: investor.mylan.com. A replay of the
webcast also will be available on the website.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 7,500 marketed products around the world,
including antiretroviral therapies on which more than 40% of people
being treated for HIV/AIDS globally depend. We market our products
in more than 165 countries and territories. We are one of the
world's largest producers of active pharmaceutical ingredients.
Every member of our approximately 35,000-strong workforce is
dedicated to creating better health for a better world, one person
at a time. Learn more at Mylan.com. We routinely post information
that may be important to investors on our website at
investor.mylan.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/mylan-to-release-first-quarter-2019-financial-results-on-may-7-2019-300838928.html
SOURCE Mylan N.V.